Nintendo Wii Virtual Reality Application In Dementia

Not Applicable

Completed

• Conditions: Age-Related Memory Disorders

• Registration Number: NCT04819126
• Lead Sponsor: Kırıkkale University

Brief Summary

•This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

The aim of the present study is to investigate the effect of the virtual reality application on muscle strength and fall in individuals with Alzheimer' Dementia (AD).

Detailed Description

Purpose: This study was planned to investigate the effects of the Nintendo Wii virtual reality application on muscle strength and fall risk in individuals with AD.

Method: The study included a total of 32 volunteers between the ages of 65-80, with mild or moderate AD diagnosed. These individuals were divided into 2 groups as a training group and control group. The training group was trained with games from different categories such as balance and aerobic exercises with a Nintendo Wii virtual reality device 2 times a week for a period of 6 weeks, with 1 session lasting for 30 minutes. Mini-Mental State Test, Knee Extension Muscle Strength, Timed Up and Go Test, Tinetti Falls Efficacy Scale results of individuals were recorded in the evaluation.

Study Timeline

• Study Start: 2018-01-15
• Primary Completion: 2018-06-06
• Study Completion: 2019-01-15
• Status Verified: 2021-03
• Study First Submitted: 2021-03-10
• Study First Submitted QC: 2021-03-25
• Last Update Submitted: 2021-03-25
• Study First Posted: 2021-03-26
• Last Update Posted: 2021-03-26

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• included volunteers between the ages of 65-80 with mild or moderate AD diagnosis,
• who did not have any difficulty or problems in communicating,
• who did not have any neurological diseases that disrupt balance and coordination such as a cerebrovascular event, Parkinson's disease, Multiple Sclerosis, and neurological disorder,
• who obtained a score of 18 - 24 points in the Mini-Mental State Test (MMST)

Exclusion Criteria

• Patients diagnosed with rapidly progressing dementia (infection, vascular, hematologic diseases),
• Those who could not be contacted during the follow-up period or who did not participate in the training session, those who experienced cardiac and cerebrovascular events, endocrine disorders, fluid-electrolyte imbalance and infection,
• Those with malignancy and those who received chemotherapy and radiotherapy that causes malignancy, delirium or depression and malignant sensory loss (those with the Semmes-Weinstein monofilament thickness of 4.56 and above),
• Those with a lower or upper extremity amputation at any level

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Sex/Gender	period of 6 weeks	Sex: Female, Male
Age :mean or median age	period of 6 weeks	Age, Categorical: \>=65 years
Body Mass Index	period of 6 weeks	BMI was recorded in kg/m\^2.

Secondary Outcome Measures

Name	Time	Method
The Mini-Mental State Test for Cognitive status	period of 6 weeks	According to the MMST, 24-30 points were considered as normal cognitive levels, 18-23 points were considered as mild cognitive disorders, and 0-17 points were considered as severe cognitive disorders

Trial Locations

Locations (1)

Karaman Ahmet Mete Nursing Home; 🇹🇷 Konya, Turkey